跳至主要内容
临床试验/NCT04579263
NCT04579263已完成不适用

Assessment of Improvement in Glycemic Control, Weight, and Insulin Sensitivity in Obese Patients After Fecal Microbiota Transplantation (FMT) Against the Background of Glucose-lowering Therapy

Federal Research and Clinical Center of Physical-Chemical Medicine4 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2020年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2
试验地点
4
主要终点
Change in insulin sensitivity within FMT, 6 months after FMT]

研究概览

简要总结

Search for mechanisms of the effect of fecal microbiota transplantation on patients with obesity

详细描述

  1. To select recipients of fecal samples according to eligibility criteria;
  2. To perform fecal microbiota transplantation for patients with obesity;
  3. To analyze the efficacy of fecal microbiota transplantation for patients with obesity within six months after therapy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • age of patients - from 18 to 75 years, both sexes;
  • patients with obesity (body mass index ≥40
  • patient's informed consent to perform fecal microbiota transplantation

排除标准

  • presence of a concomitant chronic infectious disease or malignancy
  • patients with a proven allergy to foods not excluded from the donor's diet
  • absence of the patient for one or more intermediate stages of the examination.
  • informed refusal to continue therapy

结局指标

主要结局

Change in insulin sensitivity within FMT, 6 months after FMT]

时间窗: 6 months after FMT

participants will undergo euglycaemic glucose clamp study

次要结局

未报告次要终点

研究者

发起方
Federal Research and Clinical Center of Physical-Chemical Medicine
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验